Financials

  • Market Capitalization 8.59 B
  • Employee 399
  • Founded 1993
  • CEO Michael S Weiss
  • Website www.tgtherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000FVZQY1
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
20.05
Rapporto prezzo/fatturato
10.98

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
972
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
84.95 USD+0.13%+0.14%+1.53%+106.69%9.01 B USD
980
ABVX
Abivax SA - American Depositary Shares
113.67 USD+1.74%-2.85%-5.59%+37.98%8.93 B USD
1010
APGE
Apogee Therapeutics, Inc. - Common Stock
135.08 USD0.00%+0.19%+0.72%+152.06%8.40 B USD
1013
IBRX
ImmunityBio, Inc. - Common Stock
7.87 USD-1.01%-3.67%+9.61%+229.29%8.34 B USD

Notizie